Alvotech Reiterates Meeting US Humira Biosimilar Launch Date

As Partner Cipla Bags Australian Approval For AVT02 Adalimumab Asset

 
• By Dean Rudge
FDA building.
Teva has commercialization rights in the US • Source: Shutterstock

More from Biosimilars

More from Products